Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
01 Juni 2023 - 11:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the Month of May, 2023
Commission File Number: 001-41174
RELIEF THERAPEUTICS Holding SA
(Exact name of Registrant as specified in its charter)
Not Applicable
(Translation of registrant's name into English)
Switzerland
(Jurisdiction of incorporation or organization)
Avenue de Sécheron 15
1202 Geneva
Switzerland
Tel: +41 22 545 11 16
(Address of principal executive offices)
Indicate by check mark if the registrant files or
will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) ☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7) ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On May 26, 2023, Relief Therapeutics Holding SA (the "Company")
issued a press release entitled "Relief Therapeutics Holding SA Announces Notice of Annual General Meeting of Shareholders".
A copy of the press release is attached to this Form 6-K as Exhibit 99.1.
INDEX TO EXHIBITS
- 2 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
RELIEF THERAPEUTICS Holding SA
By: /s/ Jack Weinstein
Jack Weinstein
Chief Executive Officer
Dated: June 1, 2023
- 3 -
Relief Therapeutics (QB) (USOTC:RLFFD)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Relief Therapeutics (QB) (USOTC:RLFFD)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Relief Therapeutics Holdings AG (QB) (OTCMarkets): 0 Nachrichtenartikel
Weitere Relief Therapeutics Holding Sa News-Artikel